Igyxos
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $9.2M
Investors
- 5
About Igyxos
A.A. specializes in infertility therapeutics, including its lead clinical candidate IGX12.196 mn.Igyxos Biotherapeutics specializes in developing innovative therapeutic solutions for infertility, focusing on monoclonal antibodies, with its flagship candidate IGX12 aimed at enhancing the effectiveness of Follicle Stimulating Hormone (FSH).8.A.40 mn to support its growth strategies. The company aims to launch new infertility treatments, including additional monoclonal antibodies, while expanding its market presence in Europe, North America, and Asia.
Who invested in Igyxos
5 investors across 3 rounds
See all investors in Igyxos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Igyxos
Who invested in Igyxos?
Igyxos has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Igyxos raised?
Igyxos has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Igyxos last raise money?
Igyxos's most recent round on record is a Series A, in Oct 2021.
What does Igyxos do?
Igyxos is a pharmaceuticals company.
Where is Igyxos headquartered?
Igyxos is headquartered in France.
Which VCs invest in companies like Igyxos?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Igyxos's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Igyxos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.